CDC Looking to Break Up MMR Vaccine?
On Oct. 6, 2025, the acting director of the U.S. Centers for Disease Control and Prevention (CDC), Jim O’Neill, called on the manufacturers of the live attenuated MMR (measles, mumps, rubella) vaccine to break up the biologic and develop separate shots for the three diseases it targets. “I call on vaccine manufacturers to develop safe […]
How Pfizer Lied and Covered Up COVID Vaccine Injuries of Young Maddie de Garay
What was meant to be a quick vaccine trial process resulted in long-lasting health challenges for Maddie. … Before Maddie got her final dose of the [Pfizer mRNA COVID] vaccine, she was a healthy 12-year-old who got straight A’s and had lots of friends. She had a life, she was energetic. Upon receiving the second […]
The Third Rail: Covid-19 Vaccines and Cancer
I’m going to touch on a highly controversial subject, one that has become the third rail among cancer biologists and the broader medical community: the possible link between Covid-19 vaccination and cancer. Because my laboratory’s mission is centered on cancer prevention, I cannot in good conscience ignore the elephant in the room. As my colleague, […]
Pneumococcal Vaccines Ineffective at Reducing Hospitalizations and Deaths
Despite decades of public health campaigns promoting pneumococcal vaccination to prevent pneumonia and related deaths, new real-world evidence suggests the shots may not be delivering the expected benefits. A 2025 population-based cohort study of more than 2.2 million adults in Catalonia, Spain, published Oct. 21, 2025 in BMC Infectious Diseases, found that recipients of pneumococcal […]
Former FDA Director Regulating Vaccines Joins Eli Lilly
The former director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), Peter Marks, MD, PhD, who was responsible for the agency’s regulation of the safety and effectiveness of vaccines, joined drug giant Eli Lilly and Company after resigning from the agency on Mar. 28, 2025.1 Dr. Marks alleged […]
Sanofi Reports Decline in Flu Vaccine Sales
Sanofi SA reported a decline in vaccine sales for the third quarter of 2025, citing reduced vaccination rates and increased pricing competition in Europe and the United States. The company’s legacy vaccine business dropped nearly eight percent to €3.36 billion (US$3.9 billion), while influenza and COVID-19 shot sales fell 17 percent to €1.53 billion (US$1.78 […]